AML (Acute Myeloid Leukemia),Leukemia Phase 3 Trial: Enasidenib vs Conventional Care For Elderly With IDH2-Mutant AML Feb 10, 2023
Breast Cancer,HER2- Neoadjuvant Evaluation of Ganetespib in Stage II/III Breast Cancer Treatment Feb 09, 2023
Bladder Cancer,Genitourinary Cancer Bacterial Microbiome DE in Bladder Cancer: Implications for Progression and Treatment Feb 09, 2023
Breast Cancer,HER2- Phase 3 Trial Analysis on HER2-Negative, Node-Positive Early Breast Cancer With Abemaciclib Plus Endocrine Therapy Effective Feb 09, 2023
SCC (Squamous Cell Carcinoma),Skin Cancer Combining PD-1 Antibody and Chemotherapy for Low PD-L1 ESCC: Clinical Benefits Feb 09, 2023
